P.F508del editing in cells from cystic fibrosis patients.

Autor: Smirnikhina SA; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Kondrateva EV; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Adilgereeva EP; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Anuchina AA; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Zaynitdinova MI; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Slesarenko YS; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Ershova AS; Nazarbayev University, School of Science and Technology, Nur-Sultan, Republic of Kazakhstan., Ustinov KD; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Yasinovsky MI; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Amelina EL; Laboratory of Cystic Fibrosis, Research Institute of Pulmonology, Moscow, Russian Federation., Voronina ES; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Yakushina VD; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Tabakov VY; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation., Lavrov AV; Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, Russian Federation.

Publikováno v: PloS one [PLoS One] 2020 Nov 11; Vol. 15 (11), pp. e0242094. Date of Electronic Publication: 2020 Nov 11 (Print Publication: 2020).